Ftse Mib
33.046,12
1,17%
DAX
18.132,80
0,62%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.170,67
-0,70%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Pharming Group NV (PHARM) Pharming Group NV (PHARM) Notizie

Pharming Group NV

PHARM
0,7445
0,0015 (0,20%)
Ultimo aggiornamento: 09:24:58
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
03/6/202408:00GLOBEPharming Group to participate in June investor conferences
30/5/202422:44GLOBEPharming Group provides update on ongoing regulatory review..
21/5/202417:30GLOBEPharming Group reports on results of the 2024 Annual General..
20/5/202408:00GLOBEPharming Group to participate in May investor conference
15/5/202407:00GLOBEPharming Group announces the early redemption of the..
08/5/202407:00GLOBEPharming Group reports first quarter 2024 financial results..
24/4/202408:00GLOBEPharming Group to report first quarter 2024 financial..
24/4/202407:00GLOBEPharming to be honored as Industry Innovator at National ..
19/4/202418:43GLOBEPharming Group announces the repurchase of outstanding €125..
18/4/202415:04GLOBEPharming Group announces the placement of €100 million..
18/4/202408:00GLOBEPharming Group announces the launch of an offering of..
08/4/202407:00GLOBEPharming announces completion of enrollment in pediatric..
04/4/202408:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
04/4/202407:00GLOBEPharming Group announces the filing of its 2023 Annual..
03/4/202408:00GLOBEPharming Group to participate in April investor conferences
14/3/202407:00GLOBEPharming Group reports fourth quarter and full year 2023..
29/2/202408:00GLOBEPharming Group to report fourth quarter and full year 2023..
08/2/202408:00GLOBEPharming Group to participate in February investor..
08/1/202407:00GLOBEPharming Group announces updated full year 2023 guidance and..
13/12/202307:00GLOBEPharming Group announces development plans for leniolisib..
21/11/202307:00GLOBEPharming announces first patient dosed in pediatric clinical..
10/11/202314:51GLOBEPharming Group provides updates on EMA regulatory review of..
01/11/202308:00GLOBEPharming Group to participate in November investor..
26/10/202307:00GLOBEPharming Group reports third quarter 2023 financial results
12/10/202308:00GLOBEPharming Group to report third quarter 2023 financial..
25/9/202316:00GLOBEPharming Group reports on results of the 2023 Extraordinary..
Apertura: 0,747 Min: 0,739 Max: 0,747
Chiusura: 0,743

La tua Cronologia

EU
PHARM
Pharming Group NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network